Toury R, Belqasmi F, Hauchecorne M, Leguellec D, Heizmann C W, Balmain N
Hopital Robert Debré, INSERM U120 alliée CNRS, Paris, France.
Bone. 1995 Aug;17(2):121-30. doi: 10.1016/s8756-3282(95)00153-0.
This study describes the localization of alpha-parvalbumin, in undecalcified tibial epiphyseal cartilage and bone of growing rats by immunocytochemistry in the light microscope, and of parvalbumin mRNA by in situ hybridization. They were compared to the distribution of the calbindin-D9K and its mRNA in rat epiphyseal cartilage. All the chondrocytes of the epiphyseal cartilage were parvalbumin-immunopositive, but there was no parvalbumin immunoreactivity in the uncalcified or calcified extracellular cartilage matrix. The intensity of the immunostaining increased from the resting and proliferative to the mature and hypertrophic chondrocytes, with the greatest intensity in the terminal hypertrophic chondrocytes in the calcifying zone. The parvalbumin immunostaining was located in the cytoplasm, but no immunoreactivity was detected in any chondrocyte processes. The parvalbumin mRNA distribution and levels, as revealed by in situ hybridization, exactly mirrored those of the parvalbumin protein. In contrast to parvalbumin, calbindin-D9K and its mRNA appeared in mature chondrocytes and decreased in hypertrophic up to calcifying chondrocytes. Calbindin-D9K was located in the cytoplasm and all along the cell processes. In bone, the osteoblasts and the osteocytes of trabecular and compact cortical bones were immunoreactive for parvalbumin and contained parvalbumin mRNA. Parvalbumin lay in their cytoplasm, but there was no parvalbumin immunostaining in the extracellular uncalcified or mineralized bone matrix. The long processes of osteocytes, in compact bone only, were parvalbumin immunoreactive. Osteoclasts contained cytoplasmic parvalbumin immunoreactivity. Thus, the pattern of immunoreactive parvalbumin distribution indicates that the protein is not involved in the extracellular mineralization of cartilage and bone matrix. It appears to be associated with specific calcium-related intracellular functions in chondrocytes and in osteoblasts, osteocytes, and osteoclasts. As the highest cytoplasmic concentration of parvalbumin is in the terminal hypertrophic chondrocytes, parvalbumin could act as a calcium buffer to delay the death of chondrocytes. In compact bone, parvalbumin could also have a role throughout the osteocyte processes in regulating the fluxes of calcium ions for mineral homeostatis.
本研究通过光学显微镜下的免疫细胞化学方法,描述了生长中大鼠未脱钙胫骨骨骺软骨和骨中α-小白蛋白的定位,以及通过原位杂交法对小白蛋白mRNA的定位。将它们与大鼠骨骺软骨中钙结合蛋白-D9K及其mRNA的分布进行了比较。骨骺软骨的所有软骨细胞均为小白蛋白免疫阳性,但在未钙化或钙化的细胞外软骨基质中没有小白蛋白免疫反应性。免疫染色强度从静止和增殖软骨细胞到成熟和肥大软骨细胞逐渐增加,在钙化区的终末肥大软骨细胞中强度最大。小白蛋白免疫染色位于细胞质中,但在任何软骨细胞突起中均未检测到免疫反应性。原位杂交显示的小白蛋白mRNA分布和水平与小白蛋白蛋白的分布和水平完全一致。与小白蛋白不同,钙结合蛋白-D9K及其mRNA出现在成熟软骨细胞中,并在肥大直至钙化软骨细胞中减少。钙结合蛋白-D9K位于细胞质中并沿细胞突起分布。在骨中,小梁骨和致密皮质骨的成骨细胞和骨细胞对小白蛋白呈免疫反应,并含有小白蛋白mRNA。小白蛋白位于它们的细胞质中,但在细胞外未钙化或矿化的骨基质中没有小白蛋白免疫染色。仅在致密骨中,骨细胞的长突起呈小白蛋白免疫反应性。破骨细胞含有细胞质小白蛋白免疫反应性。因此,免疫反应性小白蛋白的分布模式表明该蛋白不参与软骨和骨基质的细胞外矿化。它似乎与软骨细胞和成骨细胞、骨细胞及破骨细胞中特定的钙相关细胞内功能有关。由于小白蛋白在细胞质中的最高浓度存在于终末肥大软骨细胞中,小白蛋白可能作为钙缓冲剂来延迟软骨细胞的死亡。在致密骨中,小白蛋白在整个骨细胞突起中也可能在调节钙离子通量以维持矿物质稳态方面发挥作用。